# 18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer

> **NCT01636674** · NA · UNKNOWN · sponsor: **Naestved Hospital** · enrollment: 66 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **OTHER:** 18F-fluordeoxyglucose positron emission tomography/ computed tomography

## Key facts

- **NCT ID:** NCT01636674
- **Lead sponsor:** Naestved Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2012-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01636674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01636674, "18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01636674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*